• SENSEX 76,443.37
    418.86 (+0.55%)
  • BANKNIFTY 50,827.50
    -737.35 (--1.43%)
  • IndusInd Bank
    700.65 1,576.00(%)
  • ICICI BLR Growth
    1,003.14 1,001.47(%)
  • Bharat Electron
    274.50 204.00(%)
  • Vodafone Idea
    8.33 19.15(%)
  • SRF
    2,939.00 3,074.95(%)
  • SpiceJet
    46.10 79.90(%)
  • Mazagon Dock
    2,601.00 2,929.98(%)
  • ICICI Bank
    1,338.00 1,372.50(%)
  • M & M
    2,660.50 3,276.30(%)
  • Emcure Pharma
    1,095.80 1,577.50(%)
  • Kalyan Jewellers
    495.00 794.60(%)
  • Aegis Logistics
    830.35 1,035.70(%)
  • Hind.Aeronautics
    4,244.85 5,675.00(%)
  • Tata Consumer
    1,073.55 1,247.39(%)
  • Zomato Ltd
    205.00 304.50(%)
  • Adani Green
    939.70 2,173.65(%)
  • Tata Motors
    676.40 1,179.05(%)
  • Birlasoft Ltd
    393.85 791.95(%)
  • Quadrant Future
    583.50 743.45(%)
  • Zerodha Nifty 1D
    107.86 108.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Emcure Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 16966.0
  • ISIN : INE168P01015
1,076.05 4 (0.34%)
  • As on 02 Apr 2025 (EOD)

  • Today’s Low

    1,049.95

  • Today’s High

    1,092.00

  • Open

    1,070.00

  • Perv Close

    1,072.40

  • 52W Low

    910.95

  • 52W High

    1,580.00

Key Indicators

  • P/E(TTM)

    95.19

  • Mar.Cap (₹Cr.)

    20,383.81

  • Div & Yield %

    0.18

  • Book Value(₹)

    149.32

  • Debt-Equity Ratio

    0.34

  • AGM Date

    01-Apr-2025

  • EPS

    11.31

  • P/E Ratio

    95.19

Financials Ratios

  • Debt-Equity Ratio

    0.86

  • Mar.Cap (₹Cr.)

    20,383.81

  • RONW (%)

    19.35

  • ROCE (%)

    18.23

Score Board

  • Equity (₹ in Cr.)

    189.43

  • BV (₹)

    149.30

  • Sales( ₹ in Cr.)

    3,497.66

  • NP (in Cr.)

    162.48

  • NP Var(%)

    -1.0

  • Div%

    20.0

  • CPS (₹)

    19.40

  • EPS (₹)

    8.60

  • Traded Value (₹ in Lakhs)

    20,393.29

  • 52 Week High

    1,580.00

  • 52 Week Low

    910.95

  • Price BSE

    1077.0

  • Price NSE

    1,076.00

  • Market Capital( in Cr.)

    20,393.29

  • P/C Ratio

    55.50

  • P/E Ratio

    125.60

  • Price Vs.BV

    8.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 3,497.66 3,107.09 3,387.24 3,107.41 2,375.71 2,453.70
Excise Duty 3,444.02 3,045.33 3,299.08 3,051.31 2,332.64 2,404.39
Net Sales 3,497.66 3,107.09 3,387.24 3,107.41 2,375.71 2,453.70
Other Income 138.26 125.35 132.68 96.52 137.62 90.88
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 3,635.91 3,232.44 3,519.92 3,203.93 2,513.32 2,544.58
EXPENDITURE :
Raw Materials 3,444.02 3,045.33 3,299.08 3,051.31 2,332.64 2,404.39
Power & Fuel Cost 3,444.02 3,045.33 3,299.08 3,051.31 2,332.64 2,404.39
Employee Cost 706.41 649.18 603.95 543.92 545.35 516.14
Other Manufacturing Expenses 154.90 89.44 114.78 87.92 59.02 94.88
Selling & Administrative Expenses 532.87 443.20 263.11 226.17 369.72 279.22
Miscellaneous Expenses 154.90 89.44 114.78 87.92 59.02 94.88
Less : Pre-operative Expenses Capitalised :
Total Expenditure 3,426.69 3,013.95 2,903.50 2,639.89 2,244.48 2,139.79
Operating Profit 298.62 273.08 291.85 271.50 167.04 248.26
Interest 166.09 166.83 145.14 118.28 137.22 126.65
Gross Profit 199.91 212.34 616.42 559.52 224.68 369.84
Depreciation 204.83 178.52 165.79 154.21 154.97 129.84
Profit Before Tax 199.91 212.34 616.42 559.52 224.68 369.84
Tax 38.58 53.10 152.62 144.29 72.81 91.35
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.50 -0.83 -0.24 -4.23 -23.34 -5.17
Reported Net Profit 160.83 160.06 446.81 422.10 175.21 283.65
Extraordinary Items 199.91 212.34 616.42 559.52 224.68 369.84
Adjusted Net Profit 160.83 160.06 446.81 422.10 175.21 283.65
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 -2.07 0.00 0.00
Statutory Appropriations 36.17 36.17 54.26 18.09 45.21 0.00
P & L Balance carried down 160.83 160.06 446.81 422.10 175.21 283.65
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 20.00 20.00 30.00 10.00 25.00 0.00
Dividend Per Share(Rs) 2.00 2.00 3.00 1.00 2.50 0.00
Earnings Per Share-Unit Curr 8.89 8.85 24.71 23.25 9.69 15.68
Book Value 36.17 36.17 54.26 18.09 45.21 0.00
Book Value(Adj)-Unit Curr 36.17 36.17 54.26 18.09 45.21 0.00

Shareholding Pattern

  • Promoter Group

    77.94%

  • Public Share Holding

    22.06%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 433,932 433,932.00 433,932 433,932
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 433,932 0.23 433,932 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 118,187,350 62.39 118,187,350 16
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 29,028,000 15.32 29,028,000 2
Others 0 0.00 0 0
Sub Total 147,215,350 77.71 147,215,350 18
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 5,775,082 3.05 5,775,082 46
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 687,157 0.36 687,157 6
Mutual Funds / UTI 5,866,097 3.10 5,866,097 20
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 773,087 0.41 773,087 19
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 13,101,423 6.92 13,101,423 91
2] Non Institution
Bodies Corporate 716,256 0.38 716,256 290
Clearing Members 58 0.00 58 3
Directors of their Relatives 343,930 0.18 343,930 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,096,620 0.58 1,096,620 892
Foreign Non Institution Other 16,439,459 8.68 16,439,459 1
Hindu Undivided Families 176,880 0.09 176,880 3,469
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 5,630,986 2.97 5,630,986 32
Individuals holding nominal share capital up to Rs. 1 lakh 4,102,884 2.17 4,102,884 138,613
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 330 0.00 330 2
Others 30,750 0.02 30,750 1
Sub Total 28,681,142 15.14 28,681,142 143,338
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 189,431,847 100.00 189,431,847 143,449

Company Background

Emcure Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Emcure Pharmaceuticals Ltd
  • BSE Code : 16966.0
  • ISIN : INE168P01015

  • Incorporation Year

    1981

  • Registered Office

    Plot # P-1 & P-2 IT BT Park
    Phase II MIDC Hinjawadi, Pune,
    Maharashtra-411057

  • Telephone

    +91 20 3507 0033/+91 20 3507 0000

  • FAX

  • Chairman

    Berjis M Desai

  • Managing Director

    SATISH RAMANLAL MEHTA

  • Company Secretary

    CHETAN RAJENDRA SHARMA

  • Auditor

    B S R & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Emcure Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Emcure Pharma 1,076.55 3,635.91 3,497.66 98.77 10.08
Abbott India 30,305.85 6,097.18 5,848.91 48.26 44.71
Astrazeneca Phar 8,518.55 1,330.33 1,295.53 219.61 33.26
P & G Health Ltd 5,152.30 1,166.89 1,151.26 36.15 39.76
Glaxosmi. Pharma 2,793.40 3,530.73 3,407.25 55.55 44.44
Cipla 1,444.55 17,645.00 16,574.34 24.77 20.10
Amrutanjan Healt 642.85 437.58 421.23 37.68 20.84
Fermenta Biotec. 285.30 315.24 307.09 27.04 4.10
Guj. Themis Bio. 271.85 174.19 169.82 56.28 44.82
Bliss GVS Pharma 119.25 638.96 605.46 27.29 11.19
Ambalal Sarabhai 36.15 11.70 3.81 15.45 1.92